Skip to content

Multicenter trial of therapeutic angiogenesis in patients with intractable vasculitis

Multicenter trial of therapeutic angiogenesis in patients with intractable vasculitis - Therapeutic angiogenesis in intractable vasculitis

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000000939
Enrollment
40
Registered
2007-12-10
Start date
2004-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intractable vasculitis

Interventions

Implantation of bone marrow or peripheral blood mononuclear cells

Sponsors

Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Intractable vasculitis patients with severe peripheral ischemia resistant to conventional therapies.

Exclusion criteria

Exclusion criteria: Patients with malignancy or severe diabetic retinopathy.

Design outcomes

Primary

MeasureTime frame
Amputation, Pain scale, Ischemic ulcer size

Secondary

MeasureTime frame
Clinical symptom (numbness, coldness), Skin temperature, Blood flow (Lazer Doppler image, angiography)

Countries

Japan

Contacts

Public ContactAtsushi Izawa

Shinshu University Graduate School of Medicine Department of Cardiovascular Medicine

izawa611@shinshu-u.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026